Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: Advantages and disadvantages
Akira Mima
Topics & Concepts
ErythropoietinMedicineKidney diseaseAnemiaHepcidinDialysisErythropoiesisInternal medicineHypoxia-inducible factorsImmunologyBiologyBiochemistryGeneErythropoietin and Anemia TreatmentCancer, Hypoxia, and MetabolismErythrocyte Function and Pathophysiology